The secretion of amyloid β-peptides is inhibited in the tacrine- treated human neuroblastoma cells

Molecular Brain Research

Volumn 62, Issue 2, 1998, Pages 131-140

  Lahiri, Debomoy K ^a   Farlow, Martin R ^a   Sambamurti, Kumar ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Peptide; Amyloid precursor protein; Alzheimer's disease; Anticholinesterase; Neuroblastoma cell; Protein processing; Protein transport; THA

Indexed keywords

AMYLOID BETA PROTEIN; CHOLINESTERASE INHIBITOR; TACRINE;

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HUMAN; HUMAN CELL; NEUROBLASTOMA CELL; PATHOGENESIS; PEPTIDE ANALYSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN PROCESSING; PROTEIN SECRETION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; AMYLOID PRECURSOR PROTEIN SECRETASES; ASPARTIC ENDOPEPTIDASES; BIOLOGICAL TRANSPORT; CULTURE MEDIA, CONDITIONED; ENDOPEPTIDASES; HUMANS; L-LACTATE DEHYDROGENASE; NEUROBLASTOMA; NEURONS; PEPTIDE FRAGMENTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; SOLUBILITY; TACRINE; TUMOR CELLS, CULTURED;

EID: 0032569990     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00236-8     Document Type: Article

References (27)

1. R. Becker, E. Giacobini, P. Robert, Alzheimer's Disease: Molecular Biology to Therapy Birkhauser, Boston, MA, 1996.
2. Buxbaum J.D., Gandy S.E., Cicchetti P., Ehrlich M.E., Czernik A.J., Fracasso R.P., Ramabhadran T.V., Unterbeck A.J., Greengard P. Processing of Alzheimer β/A4 amyloid precursor protein: modulation by agents that regulate protein phosphorylation. Proc. Natl. Acad. Sci. U.S.A. 87:1990;6003-6006.
3. Checler F. Processing of the β-amyloid precursor protein and its regulation in Alzheimer's disease. J. Neurochem. 65:1995;1431-1444. and references therein.
4. Chong Y.H., Suh Y.H. Amyloidogenic processing of Alzheimer's amyloid precursor protein in vitro and its modulation by metal ions and tacrine. Life Sci. 59:1995;545-557.
5. Dell'Antone P., Bragadin M., Zatta P. Anticholinesterase drugs: tacrine but not physostigmine, accumulates in acidic compartments of the cells. Biochim. Biophys. Acta. 1270:1995;137-141.
6. De Strooper B., Umans L., Van Leuven F., Van Den Berghe H. Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway. J. Cell Biol. 121:1993;295-304.
7. Dyrks T., Monning U., Beyreuther K., Turner J. Amyloid precursor protein secretion and β A4 amyloid generation are not mutually exclusive. FEBS Lett. 349:1994;210-214.
8. Farlow M.R., Gracon S.I., Hershey L.A., Lewis K.W., Sadowsky C.H., Dolan-Ureno J. A controlled trial of tacrine in Alzheimer's disease. J. Am. Med. Assoc. 268:1992;2523-2529.
9. Greig N.H., Pei X.-F., Soncrant T.T., Ingram D.K., Brossi A. Phenserine and ring C hetero-analogues: drug candidates for the treatment of Alzheimer's disease. Med. Res. Revs. 15:1995;3-31.
10. Hsiao K., Chapman P., Nilsen S., Eckman C., Harigaya Y., Younkin S., Yang F., Cole G. Correlative memory deficits, Aβ elevation, and amyloid plaques in transgenic mice. Science. 274:1996;99-102.
11. Kuentzel S.L., Ali S.M., Altman R.A., Greenberg B.D., Raub T.J. The Alzheimer β-amyloid protein precursor/protease nexin-II is cleaved by secretase in a trans-Golgi secretory compartment in human neuroglioma cells. Biochem. J. 295:1993;367-378.
12. Lahiri D.K., Farlow M.R. Differential effect of tacrine and physostigmine on the secretion of the β-amyloid precursor protein in cell lines. J. Mol. Neurosci. 7:1996;41-49.
13. Lahiri D.K., Farlow M.R., Sambamurti K., Nall C. The effect of tacrine and leupeptin on the secretion of the β-amyloid precursor protein in HeLa cells. Life Sci. 61:1997;1985-1992.
14. Lahiri D.K., Lewis S., Farlow M.R. Tacrine alters the processing of β-amyloid precursor protein in different cell lines. J. Neurosci. Res. 37:1994;777-787.
15. Lamy P.P. The role of cholinesterase-inhibitors in Alzheimer's disease. CNS Drugs. 2:1994;146-165.
16. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron. 10:1993;243-254.
17. McNally W.P., Pool W.F., Sinz M.W., Dehart P., Ortwine D.F., Huang C.C., Chang T., Woolf T.F. Distribution of tacrine and metabolites in rat brain and plasma after single- and multiple-dose regimens. Evidence for accumulation of tacrine in brain tissue. Drug Metab. Disp. 24:1996;628-633.
18. Plemper R.K., Bohmler S., Bordallo J., Sommer T., Wolf D.H. Mutant analysis links the translocon and BiP to retrograde protein transport for ER degradation. Nature. 388:1997;891-895.
19. Querfurth H.W., Selkoe D.J. Calcium ionophore increases amyloid β-peptide by cultured cells. Biochemistry. 33:1994;4550-4661.
20. Sambamurti K., Shioi J., Anderson J.P., Pappolla M.A., Robakis N.K. J. Neurosci. Res. 33:1992;319-329.
21. Sandbrink R., Hartmann T., Masters C.L., Beyreuther K. Genes contributing to Alzheimer's disease. Mol. Psychiat. 1:1996;27-40. and references therein.
22. Selkoe D.J. Alzheimer's disease: genotypes, phenotypes, and treatments. Science. 275:1997;630-631. and references therein.
23. Seubert P., Oltersdorf T., Lee M.G., Barbour R., Blomquist C., Davis D.L., Bryant K., Fritz L.C., Galasko D., Thal L.J., Lieberburg I., Schenk D.B. Secretion of β-Amyloid precursor protein cleaved at the amino terminus of the β-amyloid peptide. Nature. 361:1993;260-263.
24. Suzuki N., Cheung T.T., Cai X.D., Odaka A., Otvos L. Jr., Eckman C., Golde T.E., Younkin S.G. An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (β APP717) mutants. Science. 264:1994;1336-1340.
25. Tomita S., Kirino Y., Suzuki T. Cleavage of Alzheimer's amyloid precursor protein (APP) by secretases occurs after O-glycosylation of APP in the protein secretory pathway. Identification of intracellular compartments in which APP cleavage occurs without using toxic agents that interfere with protein metabolism. J. Biol. Chem. 273:1998;6277-6284.
26. Wang R., Sweeney D., Gandy S.E., Sisodia S.S. The profile of soluble amyloid β protein in cultured cell media. Detection and quantification of amyloid β protein and variants by immunoprecipitation-mass spectrometry. J. Biol. Chem. 271:1996;31894-31902.
27. Zong Z., Higaki J., Murakami K., Wang Y., Catalano R., Quon D., Cordell B. Secretion of β amyloid precursor protein involves multiple cleavage sites. J. Biol. Chem. 269:1994;627-632.